The 7 most noteworthy health innovations of 2019

Doctors and researchers spend hours trying to understand, solve, and treat the disease. Some diseases are more difficult to analyze and design, while others have been ignored for many years. Newly approved drugs, treatments and health tools this year provide highlights for these often neglected diseases and bring new vitality to more mundane diseases. These innovations include the first ever drug specifically designed to treat depression common to new mothers, better forms of toothpaste, and gadgets that make checking and controlling blood pressure easier than ever. They also emphasize our understanding of the continuous improvement of human functioning.



Sanofi and Merck's Vaxelis

Asking your child to see a doctor for a scheduled vaccination can be metaphorical and literal pain. But missed or delayed shooting may put children, their friends and classmates at risk of dangerous infectious diseases. Vaxelis made by pharmaceutical giants Sanofi and Merck is the first dose to prevent six different transmitted diseases: Haemophilus influenzae B, polio virus, hepatitis B, diphtheria, tetanus And whooping cough. Babies can be taken in three doses at 2, 4, and 6 months of age (children under 4 years old can still take it). Compared to current treatment options, it requires up to four fewer injections, allowing pediatricians to focus more on other childhood needs.

Omron HeartGuide

According to the Centers for Disease Control, approximately 75 million American adults have hypertension, also known as hypertension. But even if this group of patients is at risk of heart attack, stroke, and kidney disease, only about half are under control of the disease. Continuous vigilance may help: With HeartGuide, the first FDA-approved smartwatch, people can track their stress at any time. The device has an inflatable strap that functions like a blood pressure cuff. It records readings in 30 seconds and saves the last 100 statistics so that users can view trends and share them with doctors.

Aemcolo of Cosmo Technologies Ltd.

Holidays are one of the best fun in life, but taking this path often comes with risks. Traveler's diarrhea, although common and inconvenient, can lead to more serious illness if left untreated. For this reason, doctors often turn to broad-spectrum antibiotics, which can lead to resistance if not used properly. Aemcolo is an antibiotic pill that has been approved in the United States to combat the most common non-invasive E. coli strain, the most common cause of diarrhea in travelers. It targets the colon, not the blood, to keep the resistance down.

Cerene cryotherapy unit from Channel Medsystems

Heavy menstrual bleeding or bleeding that lasts more than a week can cause iron deficiency anemia, which is a potentially dangerous condition. Often, treatments include surgery under general anesthesia, but Channel Medsystems offers a new option to skip the scalpel. Cerene cryotherapy devices freeze the endometrial area to significantly reduce future bleeding. The procedure is as effective as existing methods and can be performed safely in the gynecologist's office without anesthesia.

Vertex Pharmaceuticals and CRISPR Therapeutics' sickle cell therapy

Since CRISPR, an easy-to-use gene editing tool, first entered the field of biotechnology, experts have been using it in research to try to treat mutation-based diseases. In July 2019, a team edited the DNA of an American woman with sickle cell anemia for the first time. People with sickle cells lack the proteins necessary to produce healthy red blood cells, which makes it difficult for oxygen to flow through the body. Doctors first remove stem cells from a woman's bone marrow. They then genetically modified them using CRISPR so that the proteins they produce can make healthy red blood cells, but usually turn off shortly after birth. The procedure was successful, but researchers need at least two years to know how it will last in the long run.

Population Commission of Annovera

Birth control pills are very effective at regulating hormones and preventing pregnancy, but they can also cause trouble. Daily synthetic hormones require repeated visits to pharmacies and strict treatment regimens; and other forms of birth control measures, such as intrauterine devices or implants, often require long-term, multi-year commitments. Annovera is the first year of reusable implants that women can choose and reinsert when they choose. This is a vaginal ring about 2 inches wide that releases synthetic forms of estrogen (inhibits ovulation) and progesterone. The device stays in place during sex and can be used for a year, giving users greater autonomy in how and when they choose to use it.

Colgate Total SF

The dentist is right: fluoride is perfect for your teeth. It strengthens and remineralizes enamel, preventing tooth decay and even reversing early tooth decay. Currently, most toothpastes come with fluoride formulated with sodium. Colgate's PFOS contains more potent stannous fluoride, which not only enhances the enamel, but also has antibacterial effects against the bacteria causing bad breath and protects teeth and gums The effects of tartar buildup, gingivitis and sensitivity. To date, researchers have not been able to stabilize stannous fluoride without making the product yellow and dark brown. Total SF uses a unique inactive zinc phosphate system to handle tricky elements. This will ensure that your pearly white remains cavity-free and bright.

Subscribe to receive free email updates:

0 Response to "The 7 most noteworthy health innovations of 2019"

Posting Komentar